株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

タンパク質ラベリングの世界市場

Global Markets for Protein Labeling

発行 BCC Research 商品コード 447099
出版日 ページ情報 英文 176 Pages
即納可能
価格
本日の銀行送金レート: 1USD=110.75円で換算しております。
Back to Top
タンパク質ラベリングの世界市場 Global Markets for Protein Labeling
出版日: 2017年02月21日 ページ情報: 英文 176 Pages
概要

世界のタンパク質ラベリング市場は、2016年の22億米ドルから、2021年までには42億米ドルまで拡大すると見られています。市場は、2016年〜2021年のCAGR (複合年間成長率) で、14.1%の成長が予測されています。

当レポートでは、世界のタンパク質ラベリング市場について調査分析し、市場概要、市場動向、CAGRの予測、最近の動向と影響、製品、応用、主要企業プロファイルなど、体系的な情報を提供しています。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義
  • 市場の進化・技術革新
  • 品質保証・管理
  • 優れた検査実習
  • 技術動向
  • ラベリングツールの開発
  • 市場力学

第4章 タンパク質ラベリング市場:応用別

  • 細胞ベースアッセイ
  • 蛍光顕微鏡
  • 質量分析
  • 免疫学的技法
  • タンパク質マイクロアレイ

第5章 市場分析:製品別

  • キット
  • 試薬
  • 酵素
  • 西洋ワサビペルオキシダーゼ
  • アルカリホスファターゼ
  • モノクローナル抗体
  • キメラモノクローナル抗体
  • ヒトモノクローナル抗体
  • プローブ/タグ
  • タンパク質
  • サービス

第6章 タンパク質ラベリング市場の分析:ラベリング方法別

  • ラベリング方法の種類
  • 体外ラベリング
  • 体内ラベリング
  • 生体直交型ラベリング

第7章 競合情勢

  • M&A
  • 製品発売
  • パートナーシップ・提携
  • その他の戦略

第8章 タンパク質ラベリング市場の分析:地域別

  • 北米
  • 欧州
  • アジア太平洋地域
  • その他

第9章 特許分析

  • 特許分析:参入企業別
  • 特許分析:年別

第10章 企業プロファイル

  • ACTIVE MOTIF INC.
  • AGILENT TECHNOLOGIES INC.
  • BIO-RAD LABORATORIES
  • BIOTIUM INC.
  • CANDOR BIOSCIENCE GMBH
  • CAPRION BIOSCIENCES
  • F. HOFFMANN-LA ROCHE AG
  • GENERAL ELECTRIC COMPANY
  • INNOVA BIOSCIENCES LTD.
  • カネカ
  • LI-COR BIOSCIENCES
  • LUMINEX CORP.
  • MERCK & COMPANY INC.
  • NANOTEMPER TECHNOLOGIES GMBH
  • NEW ENGLAND BIOLABS INC.
  • PERKINELMER INC.
  • PROMEGA COPRPORATION
  • SERACARE LIFE SCIENCES
  • TAKARA BIO USA INC.
  • THERMO FISHER SCIENTIFIC INC.
  • QIAGEN N.V.

第11章 特許:地域別

目次
Product Code: BIO154A

Report Highlights

The global protein-labeling market reached $2.2 billion in 2016. The market should reach $4.2 billion by 2021, growing at a compound annual growth rate (CAGR) of 14.1% from 2016 to 2021.

Report Includes:

  • An overview of the global protein labeling market.
  • Analyses of global market trends, with data from 2015, 2016 and projections of compound annual growth rates (CAGRs) through 2021.
  • Coverage of most commonly used labels including biotin, reporter enzymes, fluorophores and radioactive isotopes.
  • A look at the current trends in the market as well as factors influencing demand.
  • Coverage of protein labeling products: kits, reagents and services.
  • Coverage of protein labeling applications: cell-based assays, fluorescence microscopy, mass spectrometry, immunological techniques, protein microarray.
  • Coverage of protein labeling methods: in vitro labeling, in vivo labeling and bio-orthogonal labeling.
  • Profiles of major players in the industry.

Report Scope

This research report presents an in-depth analysis of the global protein-modeling market by application, product categories, labeling methods and regional markets. It includes key labeling methods involved in vitro and in vivo labeling methods. It discusses the role of supply chain members from manufacturers to researchers. The report has an in-depth analysis of key companies operating in the global protein-labeling market. In-depth patent analysis will focus on providing extensive technological trends across years and regions, including the U.S., Europe and Japan.

The protein-labeling market is segmented into three labeling methods: in vitro labeling, in vivo labeling and biorthogonal labeling methods. In vitro labeling methods are further segmented into nanoparticle, site-specific, dye-based, cotranslational and enzymatic labeling. The in vivo labeling method market is segmented into radioactive and photoreactive labeling. The protein-labeling market is further segmented on the basis of products offered for in-depth analysis of technology markets during the analysis period. The market study is detailed for technology based on procedures, as well as its further implication on the research and development area. These two segmentations are also discussed in detail for the given period. The market is segmented by region into North America, Europe, the Asia-Pacific region and ROW. Companies profiled in this report include General Electric Company, Kaneka Corp. LI-COR Biosciences, Merck and Company Inc., New England Biolabs Inc., Perkinelmer Inc., Promega Corp., F. Hoffman-La-Roche AG, Seracare Lifesciences and Thermo Fisher Scientific Inc.

Analyst Credentials

Yojana Jeevane has more than four years of experience in market intelligence and business research. She has experience in the healthcare domain with respect to medical devices, the life sciences market and the chemical domain. She has frequently delivered research services that contain strategic recommendations and top business strategies to assist the market players to make beneficial strategies. Ms. Jeevane holds an MBA in marketing.

Table of Contents

CHAPTER 1 - INTRODUCTION

  • STUDY GOALS AND OBJECTIVES
  • STUDY BACKGROUND
  • SCOPE OF THE REPORT
  • INTENDED AUDIENCE
  • SOURCE OF INFORMATION AND METHODOLOGY
  • ANALYST'S CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 - EXECUTIVE SUMMARY

  • SUMMARY TABLE: GLOBAL PROTEIN-LABELING MARKET, BY REGION, THROUGH 2021 ($ MILLIONS)
  • SUMMARY FIGURE: GLOBAL PROTEIN-LABELING MARKET, BY REGION, 2015-2021 ($ MILLIONS)

CHAPTER 3 - MARKET OVERVIEW

  • MARKET DEFINITION
    • FIGURE 1: KEY PROTEIN LABELS USED FOR PROTEIN LABELING
    • ENZYME CONJUGATES
    • FLUORESCENT PROBES
  • MARKET EVOLUTION AND INNOVATION
  • QUALITY ASSURANCE AND CONTROL
    • QUALITY CONTROL
      • Quality Control Applications
      • Quality Control Logs
    • SPACE
    • PERSONNEL SAFETY
  • GOOD LABORATORY PRACTICES
    • FIGURE 2: COMPONENTS INVOLVED IN AN EFFECTIVE GOOD LABORATORY PRACTICE INVESTIGATION
    • TABLE 1: COMPARATIVE ANALYSIS OF U.S. FOOD AND DRUG ADMINISTRATION, ENVIRONMENTAL PROTECTION AGENCY AND ORGANIZATION FOR ECONOMIC COOPERATION AND DEVELOPMENT REGULATIONS BY PARAMETER
    • STANDARD OPERATING PROTOCOL
    • GOOD LABORATORY PRACTICE ELEMENTS
      • Protocol
      • Reports
      • Archives
      • Key Good Laboratory Practice Points
        • FIGURE 3: KEY GOOD LABORATORY PRACTICE ELEMENTS
      • Facilities and Equipment
      • Characterization
      • Test Item Control Before Formulation
        • Physical Separation
      • Equipment Suitability and Calibration
      • Maintenance
      • Good Laboratory Practice Standards for Laboratory Equipment
    • ROLE OF GOOD LABORATORY PRACTICES IN IN VITRO STUDIES
  • TECHNOLOGY TRENDS
    • SLENDR TECHNIQUE
    • NEW BIOTIN LABELS
    • ITRAQ
  • DEVELOPMENT OF LABELING TOOLS
    • MUTANT B-LACTAMASE TAG TECHNOLOGY
  • MARKET DYNAMICS
    • DRIVERS
      • Increasing Investment in Research and Development Endeavors
      • Increase in Genome Sequencing Demand
      • Increasing Healthcare Expenditure
      • Increase in Proteomics Research
    • RESTRAINTS
      • Protein-Labeling Product Application
      • Lack of Skilled Professionals
    • OPPORTUNITIES
      • Effective Protein-Labeling Technology Pricing
      • Technological Advances in Protein Labeling

CHAPTER 4 - PROTEIN-LABELING MARKET BY APPLICATION

  • TABLE 2: GLOBAL PROTEIN-LABELING MARKET, BY APPLICATION, THROUGH 2021 ($ MILLIONS)
  • CELL-BASED ASSAYS
    • HISTORY OF CELL-BASED ASSAYS
      • FIGURE 4: CELL-BASED ASSAY TYPES
    • CELL-BASED ASSAY APPLICATIONS
      • TABLE 3: GLOBAL PROTEIN-LABELING MARKET FOR CELL-BASED ASSAYS, BY REGION, THROUGH 2021 ($ MILLIONS)
    • ADVANCES IN CELL-BASED ASSAYS
  • FLUORESCENCE MICROSCOPY
    • FLUORESCENCE MICROSCOPY HISTORY
    • FLUORESCENT MICROSCOPY TECHNIQUES
    • FLUORESCENCE MICROSCOPY PROCEDURE
      • FIGURE 5: FLUORESCENCE MICROSCOPY PROTOCOL
      • Fluorescent Microscope Functioning
      • Fluorescent Microscopy Applications
    • RECENT ADVANCES IN FLUORESCENT MICROSCOPY
      • TABLE 4: GLOBAL PROTEIN-LABELING MARKET FOR FLUORESCENCE MICROSCOPY, BY REGION, THROUGH 2021 ($ MILLIONS)
  • MASS SPECTROMETRY
    • MASS SPECTROMETRY HISTORY
    • FUNCTIONS OF A MASS SPECTROMETER
      • Mass Spectrometers
        • TABLE 5: GLOBAL PROTEIN-LABELING MARKET FOR MASS SPECTROSCOPY, BY REGION, THROUGH 2021 ($ MILLIONS)
    • MASS SPECTROMETRY APPLICATIONS
    • METHODS USED FOR MASS SPECTROMETRY
      • Matrix-Assisted Laser Desorption
      • Protocol for Data Acquisition Through Matrix-Assisted Laser Desorption Time of Flight
    • MASS SPECTROMETRY ADVANCES
      • FIGURE 6: PROTEOMICS STUDY APPROACHES
  • IMMUNOLOGICAL TECHNIQUES
    • TABLE 6: GLOBAL PROTEIN-LABELING MARKET FOR IMMUNOLOGICAL TECHNIQUE APPLICATIONS, BY REGION, THROUGH 2021 ($ MILLIONS)
    • CLINICAL IMMUNOLOGY APPLICATIONS
      • Immunoassay
      • Radioimmunoassay
      • Immunoprecipitation
      • Immunoelectrophoresis
      • Immunofluorescence
      • Immunohistochemistry
      • Immunocytochemistry
      • ELISA Types
        • FIGURE 7: ELISA TYPES
        • FIGURE 8: DIRECT ELISA PROTOCOL
        • FIGURE 9: INDIRECT ELISA PROTOCOL
        • FIGURE 10: COMPETITIVE ELISA PROTOCOL
        • FIGURE 11: SANDWICH ELISA PROTOCOL
      • Immunomonitoring
      • Immunomonitoring Application
      • Diabetes Mellitus
      • Infectious Diseases
    • ADVANCES IN IMMUNOLOGICAL TECHNIQUES
  • PROTEIN MICROARRAY
    • TABLE 7: GLOBAL PROTEIN-LABELING MARKET FOR PROTEIN MICROARRAYS, BY REGION, THROUGH 2021 ($ MILLIONS)
    • PROTEIN MICROARRAY TYPES
    • PROTEIN ARRAY CLINICAL APPLICATIONS
      • FIGURE 12: METHODS FOR PROTEIN ARRAY DETECTION
    • ELISA
    • PROTEIN MICROARRAY ADVANTAGES

CHAPTER 5 - MARKET ANALYSIS BY PRODUCT

  • TABLE 8: GLOBAL PROTEIN-LABELING MARKET, BY PRODUCT, THROUGH 2021 ($ MILLIONS)
  • FIGURE 13: PROTEIN-LABELING PRODUCTS
  • KITS
    • TABLE 9: GLOBAL PROTEIN-LABELING MARKET FOR KITS, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 10: AMERSHAM CYDYE ANTIBODY LABELING KIT COMPONENTS
    • TABLE 11: AMERSHAM CYDYE MONOCLONAL ANTIBODY LABELING KIT COMPONENTS
    • TABLE 12: ZENON ANTIBODY LABELING KIT COMPONENTS
    • TABLE 13: APEX ANTIBODY LABELING KIT COMPENENTS
    • TABLE 14: MICROSCALE PROTEIN-LABELING KIT
    • TABLE 15: SITECLICK ANTIBODY LABELING KIT
    • TABLE 16: MOLECULAR PROBES' DSB-X BIOTIN PROTEIN-LABELING KIT
    • TABLE 17: ROCHE BIOTIN PROTEIN-LABELING KIT
    • TABLE 18: SNAP CELL STARTER KIT
    • TABLE 19: CLIP CELL STARTER KIT
  • REAGENTS
    • TABLE 20: GLOBAL PROTEIN-LABELING MARKET FOR REAGENTS, BY TYPE, THROUGH 2021 ($ MILLIONS)
    • TABLE 21: GLOBAL PROTEIN-LABELING MARKET FOR REAGENTS, BY REGION, THROUGH 2021 ($ MILLIONS)
  • ENZYMES
    • TABLE 22: GLOBAL PROTEIN-LABELING MARKET FOR ENZYMES, BY REGION, THROUGH 2021 ($ MILLIONS)
  • HORSERADISH PEROXIDASE
    • TABLE 23: THERMO FISHER SCIENTIFIC HORSERADISH PEROXIDASE
    • TABLE 24: BIO-RAD HORSERADISH PEROXIDASE
  • ALKALINE PHOSPHATASE
    • TABLE 25: THERMO FISHER SCIENTIFIC PIERCE ALKALINE PHOSPHATASE
    • TABLE 26: NEW ENGLAND BIOLABS ALKALINE PHOSPHATES CALF INTESTINAL
  • MONOCLONAL ANTIBODIES
    • TABLE 27: GLOBAL PROTEIN-LABELING MARKET FOR MONOCLONAL ANTIBODIES, BY REGION, THROUGH 2021 ($ MILLIONS)
  • CHIMERIC MONOCLONAL ANTIBODIES
    • TABLE 28: CHIMERIC MONOCLONAL ANTIBODIES
  • HUMAN MONOCLONAL ANTIBODIES
    • TABLE 29: HUMAN MONOCLONAL ANTIBODIES
  • PROBES/TAGS
    • TABLE 30: GLOBAL PROTEIN-LABELING MARKET FOR PROBES/TAGS, BY REGION, THROUGH 2021 ($ MILLIONS)
  • PROTEINS
    • TABLE 31: GLOBAL PROTEIN-LABELING MARKET FOR PROTEINS, BY REGION, THROUGH 2021 ($ MILLIONS)
    • BLOCKING BUFFERS
    • IODINATION REAGENTS
    • ELUTION BUFFERS
  • SERVICES
    • TABLE 33: GLOBAL PROTEIN-LABELING MARKET FOR SERVICES, BY REGION, THROUGH 2021 ($ MILLIONS)

CHAPTER 6 - PROTEIN LABELING MARKET ANALYSIS BY LABELING METHOD

  • TABLE 34: GLOBAL PROTEIN-LABELING MARKET, BY LABELING METHOD, THROUGH 2021 ($ MILLIONS)
  • FIGURE 14: PROTEIN-LABELING METHODS
  • LABELING METHOD TYPES
    • IN VITRO LABELING
      • TABLE 35: GLOBAL PROTEIN-LABELING MARKET FOR IN VITRO LABELING METHODS, BY REGION, THROUGH 2021 ($ MILLIONS)
      • TABLE 36: GLOBAL PROTEIN-LABELING MARKET FOR IN VITRO LABELING METHODS BY TYPE, THROUGH 2021 ($ MILLIONS)
      • Nanoparticle Labeling
        • Nanoparticle Applications: A Biological Perspective
          • TABLE 37: GLOBAL PROTEIN-LABELING MARKET FOR NANOPARTICLE LABELING METHODS, BY REGION, THROUGH 2021 ($ MILLIONS)
        • Nanoparticles Use in Protein Labeling
        • Luminescent Particles as Nanoparticles for Protein Labeling
          • FIGURE 15: KEY NANOPARTICLE FORMS USED IN BIOCONJUGATION
      • Site-Specific Labeling
        • TABLE 38: GLOBAL PROTEIN-LABELING MARKET FOR SITE-SPECIFIC LABELING, BY REGION, THROUGH 2021 ($ MILLIONS)
        • Site-Specific Protein Labeling Using an Integration of Unnatural Amino Acids
        • Site-Specific Protein-Labeling Using Protein Targeting Sequences
        • Site-Specif Protein Labeling Using Peptide Targeting Sequences
          • TABLE 39: SITE-SPECIFIC TAGS FOR PROTEIN-LABELING
      • Dye-Based Labeling
        • Reactive Fluorescent Dyes
        • Amine-Reactive Dyes
          • FIGURE 16: REACTIVE FLUORESCENT AGENTS
        • Thiol-Reactive Dyes
        • Amine-Containing Dyes
          • TABLE 40: GLOBAL PROTEIN-LABELING MARKET FOR DYE-BASED LABELING, BY REGION, THROUGH 2021 ($ MILLIONS)
      • Cadaverines
      • Carbonyl-Reactive Hydrazides
      • Avidin/Streptavidin-Biotin
      • Phalloidins
        • Co-Translational Labeling
          • TABLE 41: GLOBAL PROTEIN-LABELING MARKET FOR CO-TRANSLATIONAL LABELING, BY REGION, THROUGH 2021 ($ MILLIONS)
        • Enzymatic Labeling
          • TABLE 42: GLOBAL PROTEIN-LABELING MARKET FOR ENZYMATIC LABELING METHOD, BY REGION, THROUGH 2021 ($ MILLIONS)
          • FIGURE 17: ENZYMES USED FOR PROTEIN LABELING
          • Formylglycine Generating Enzyme
          • Phosphopantetheinyl Transferase
          • Transglutaminase
          • Biotin Ligase
    • IN VIVO LABELING
      • TABLE 43: GLOBAL PROTEIN-LABELING MARKET FOR IN VIVO LABELING, BY TYPE, THROUGH 2021 ($ MILLIONS)
      • TABLE 44: GLOBAL PROTEIN-LABELING MARKET FOR IN VIVO LABELING, BY REGION, THROUGH 2021 ($ MILLIONS)
      • FIGURE 18: STEPS INVOLVED IN VIVO PROTEIN-LABELING
      • Radioactive Labeling
        • TABLE 45: GLOBAL PROTEIN-LABELING MARKET FOR RADIOACTIVE LABELING METHOD, BY REGION, THROUGH 2021 ($ MILLIONS)
        • TABLE 46: RADIOACTIVE ELEMENTS
      • General Steps in Radioactive Labeling of Proteins
        • FIGURE 19: RADIOACTIVE LABELING OF PROTEINS
      • Photoreactive Labeling
        • TABLE 47: GLOBAL PROTEIN-LABELING MARKET FOR PHOTOREACTIVE LABELING METHOD, BY REGION, THROUGH 2021 ($ MILLIONS)
        • FIGURE 20: GENERAL PROTOCOL FOR PHOTOLABELING OF PROTEINS
    • BIOORTHOGONAL LABELING
      • TABLE 48: GLOBAL PROTEIN-LABELING MARKET FOR BIORTHOGONAL LABELING METHOD, BY REGION, THROUGH 2021 ($ MILLIONS)

CHAPTER 7 - COMPETITIVE LANDSCAPE

  • FIGURE 21: KEY COMPETITIVE STRATEGIES, 2014-2016 (%)
  • MERGERS AND ACQUISITIONS
    • FIGURE 22: MERGER AND ACQUISTION STRATEGIES BY COMPANY, 2014-2016
    • TABLE 49: KEY ACQUISTIONS, 2012-2016
  • PRODUCT LAUNCHES
    • FIGURE 23: PRODUCT LAUNCH STRATEGIES, BY COMPANY, 2014-2016
    • TABLE 50: KEY PRODUCT LAUNCHES, 2014-2016
  • PARTNERSHIPS AND COLLABORATIONS
    • FIGURE 24: PARTNERSHIP AND COLLABORATION STRATEGIES, BY COMPANY, 2014-2016 (%)
    • TABLE 51: KEY ANNOUNCED AGREEMENTS, 2014-2016
  • OTHER STRATEGIES
    • FIGURE 25: PARTNERSHIP AND COLLABORATION STRATEGIES, BY COMPANY, 2014-2016 (%)
    • TABLE 52: PARTNERSHIP AND COLLABORATION STRATEGIES, BY COMPANY, 2014-2016 (%)

CHAPTER 8 - PROTEIN-LABELING MARKET ANALYSIS BY REGION

  • FIGURE 26: GLOBAL MARKET FOR PROTEIN-LABELING, BY REGION, 2015 (%)
  • FIGURE 27: PATENTS GRANTED FOR PROTEIN-LABELING RESEARCH, BY REGION, 2015 (%)
  • FIGURE 28: TOP 2,500 COMPANIES RESEARCH AND DEVELOPMENT INVESTMENT, BY REGION, 2014 (%)
  • NORTH AMERICA
    • TABLE 53: NORTH AMERICAN PROTEIN-LABELING MARKET, BY PRODUCT TYPE, THROUGH 2021 ($ MILLIONS)
  • EUROPE
    • FIGURE 29: TOP 2,500 EUROPEAN COMPANIES RESEARCH AND DEVELOPMENT INVESTMENT, BY COUNTRY, 2014 (%)
    • TABLE 54: EUROPEAN PROTEIN-LABELING MARKET, BY PRODUCT TYPE, THROUGH 2021 ($ MILLIONS)
  • ASIA-PACIFIC
    • TABLE 55: ASIA-PACIFIC PROTEIN-LABELING MARKET, BY PRODUCT TYPE, THROUGH 2021 ($ MILLIONS)
  • REST OF THE WORLD
    • TABLE 56: REST OF THE WORLD PROTEIN-LABELING MARKET, BY PRODUCT TYPE, THROUGH 2021 ($ MILLIONS)

CHAPTER 9 - PATENT ANALYSIS

  • FIGURE 30: PATENTS REGISTERED AND APPROVED IN NORTH AMERICA, EUROPE, ASIA-PACIFIC AND THE REST OF THE WORLD, 2013-2016 (%)
  • PATENT ANALYSIS BY MARKET PARTICIPANTS
    • FIGURE 31: PATENT ANALYSIS, BY MARKET APPLICANT, 2013-2016 (%)
  • PATENT ANALYSIS BY YEAR
    • FIGURE 32: PATENT ANALYSIS, BY YEAR, 2013-2016 (%)

CHAPTER 10 - COMPANY PROFILES

  • ACTIVE MOTIF INC.
    • PROTEIN-LABELING PRODUCT PORTFOLIO
      • TABLE 57: ACTIVE MOTIF RECENT DEVELOPMENTS
  • AGILENT TECHNOLOGIES INC.
    • PROTEIN-LABELING PRODUCT PORTFOLIO
      • TABLE 58: AGILENT TECHNOLOGIES RECENT DEVELOPMENTS
      • TABLE 59: AGILENT TECHNOLOGIES FINANCIALS, 2013-2015 ($ MILLIONS)
  • BIO-RAD LABORATORIES
    • PROTEIN-LABELING PRODUCT PORTFOLIO
      • TABLE 60: BIO-RAD RECENT DEVELOPMENTS
      • TABLE 61: BIO-RAD FINANCIALS 2013-2015 ($ MILLIONS)
  • BIOTIUM INC.
    • PROTEIN-LABELING PRODUCT PORTFOLIO
  • CANDOR BIOSCIENCE GMBH
    • PROTEIN-LABELING PRODUCT PORTFOLIO
      • TABLE 62: CANDOR RECENT DEVELOPMENTS
  • CAPRION BIOSCIENCES
    • PROTEIN-LABELING PRODUCT PORTFOLIO
      • TABLE 63: CAPRION RECENT DEVELOPMENTS
  • F. HOFFMANN-LA ROCHE AG
    • PROTEIN-LABELING PRODUCT PORTFOLIO
      • TABLE 64: F. HOFFMANN-LA ROCHE AG RECENT DEVELOPMENTS
      • TABLE 65: F. HOFFMANN-LA ROCHE AG FINANCIALS, 2013-2015 ($ MILLIONS)
  • GENERAL ELECTRIC COMPANY
    • PROTEIN-LABELING PRODUCT PORTFOLIO
      • TABLE 66: GENERAL ELECTRIC COMPANY RECENT DEVELOPMENTS
      • TABLE 67: GENERAL ELECTRIC COMPANY FINANCIALS, 2013-2015 ($ MILLIONS)
  • INNOVA BIOSCIENCES LTD.
    • PROTEIN-LABELING PRODUCT PORTFOLIO
      • TABLE 68: INNOVA BIOSCIENCES RECENT DEVELOPMENTS
  • KANEKA CORP.
    • PROTEIN-LABELING PRODUCT PORTFOLIO
      • TABLE 69: KANEKA RECENT DEVELOPMENTS
      • TABLE 70: KANEKA FINANCIALS, 2013-2015 ($ MILLIONS)
  • LI-COR BIOSCIENCES
    • PROTEIN-LABELING PRODUCT PORTFOLIO
      • TABLE 71: LI-COR RECENT DEVELOPMENTS
  • LUMINEX CORP.
    • PROTEIN-LABELING PRODUCT PORTFOLIO
      • TABLE 72: LUMINEX, RECENT DEVELOPMENTS
      • TABLE 73: LUMINEX FINANCIALS 2013-2015 ($ MILLIONS)
  • MERCK & COMPANY INC.
    • PROTEIN-LABELING PRODUCT PORTFOLIO
      • TABLE 74: MERCK RECENT DEVELOPMENTS
      • TABLE 75: MERCK FINANCIALS, 2013-2015 ($ MILLIONS)
  • NANOTEMPER TECHNOLOGIES GMBH
    • PROTEIN-LABELING PRODUCT PORTFOLIO
      • TABLE 76: NANOTEMPER RECENT DEVELOPMENTS
  • NEW ENGLAND BIOLABS INC.
    • PROTEIN-LABELING PRODUCT PORTFOLIO
      • TABLE 77: NEW ENGLAND BIOLABS INC. RECENT DEVELOPMENTS
  • PERKINELMER INC.
    • PROTEIN-LABELING PRODUCT PORTFOLIO
      • TABLE 78: PERKINELMER RECENT DEVELOPMENTS
      • TABLE 79: PERKINELMER FINANCIALS, 2013-2015 ($ MILLIONS)
  • PROMEGA COPRPORATION
    • PROTEIN-LABELING PRODUCT PORTFOLIO
      • TABLE 80: PROMEGA RECENT DEVELOPMENTS
      • TABLE 81: PROMEGA FINANCIALS, 2013-2015 ($ MILLIONS)
  • SERACARE LIFE SCIENCES
    • PROTEIN-LABELING PRODUCT PORTFOLIO
      • TABLE 82: SERACARE LIFE SCIENCES RECENT DEVELOPMENTS
  • TAKARA BIO USA INC.
    • PROTEIN-LABELING PRODUCT PORTFOLIO
      • TABLE 83: TAKARA BIO RECENT DEVELOPMENTS
      • TABLE 84: TAKARA BIO FINANCIALS, 2013-2015 ($ MILLIONS)
  • THERMO FISHER SCIENTIFIC INC.
    • PROTEIN-LABELING PRODUCT PORTFOLIO
      • TABLE 85: THERMO FISHER RECENT DEVELOPMENTS
      • TABLE 86: THERMO FISHER FINANCIALS, 2013-2015 ($ MILLIONS)
  • QIAGEN N.V.
    • PROTEIN-LABELING PRODUCT PORTFOLIO
      • TABLE 87: QIAGEN RECENT DEVELOPMENTS
      • TABLE 88: QIAGEN FINANCIALS, 2013-2015 ($ MILLIONS)

CHAPTER 11 - PATENTS BY REGION

  • TABLE 89: NORTH AMERICAN PATENTS
  • TABLE 90: EUROPEAN PATENTS
  • TABLE 91: ASIA-PACIFIC REGION PATENTS
  • TABLE 92: REST OF THE WORLD PATENTS

LIST OF TABLES

  • SUMMARY TABLE: GLOBAL PROTEIN-LABELING MARKET, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 1: COMPARATIVE ANALYSIS OF U.S. FOOD AND DRUG ADMINISTRATION, ENVIRONMENTAL PROTECTION AGENCY AND ORGANIZATION FOR ECONOMIC COOPERATION AND DEVELOPMENT REGULATIONS BY PARAMETER
    • TABLE 2: GLOBAL PROTEIN-LABELING MARKET, BY APPLICATION, THROUGH 2021 ($ MILLIONS)
    • TABLE 3: GLOBAL PROTEIN-LABELING MARKET FOR CELL-BASED ASSAYS, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 4: GLOBAL PROTEIN-LABELING MARKET FOR FLUORESCENCE MICROSCOPY, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 5: GLOBAL PROTEIN-LABELING MARKET FOR MASS SPECTROSCOPY, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 6: GLOBAL PROTEIN-LABELING MARKET FOR IMMUNOLOGICAL TECHNIQUE APPLICATIONS, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 7: GLOBAL PROTEIN-LABELING MARKET FOR PROTEIN MICROARRAYS, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 8: GLOBAL PROTEIN-LABELING MARKET, BY PRODUCT, THROUGH 2021 ($ MILLIONS)
    • TABLE 9: GLOBAL PROTEIN-LABELING MARKET FOR KITS, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 10: AMERSHAM CYDYE ANTIBODY LABELING KIT COMPONENTS
    • TABLE 11: AMERSHAM CYDYE MONOCLONAL ANTIBODY LABELING KIT COMPONENTS
    • TABLE 12: ZENON ANTIBODY LABELING KIT COMPONENTS
    • TABLE 13: APEX ANTIBODY LABELING KIT COMPENENTS
    • TABLE 14: MICROSCALE PROTEIN-LABELING KIT
    • TABLE 15: SITECLICK ANTIBODY LABELING KIT
    • TABLE 16: MOLECULAR PROBES' DSB-X BIOTIN PROTEIN-LABELING KIT
    • TABLE 17: ROCHE BIOTIN PROTEIN-LABELING KIT
    • TABLE 18: SNAP CELL STARTER KIT
    • TABLE 19: CLIP CELL STARTER KIT
    • TABLE 20: GLOBAL PROTEIN-LABELING MARKET FOR REAGENTS, BY TYPE, THROUGH 2021 ($ MILLIONS)
    • TABLE 21: GLOBAL PROTEIN-LABELING MARKET FOR REAGENTS, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 22: GLOBAL PROTEIN-LABELING MARKET FOR ENZYMES, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 23: THERMO FISHER SCIENTIFIC HORSERADISH PEROXIDASE
    • TABLE 24: BIO-RAD HORSERADISH PEROXIDASE
    • TABLE 25: THERMO FISHER SCIENTIFIC PIERCE ALKALINE PHOSPHATASE
    • TABLE 26: NEW ENGLAND BIOLABS ALKALINE PHOSPHATES CALF INTESTINAL
    • TABLE 27: GLOBAL PROTEIN-LABELING MARKET FOR MONOCLONAL ANTIBODIES, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 28: CHIMERIC MONOCLONAL ANTIBODIES
    • TABLE 29: HUMAN MONOCLONAL ANTIBODIES
    • TABLE 30: GLOBAL PROTEIN-LABELING MARKET FOR PROBES/TAGS, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 31: GLOBAL PROTEIN-LABELING MARKET FOR PROTEINS, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 33: GLOBAL PROTEIN-LABELING MARKET FOR SERVICES, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 34: GLOBAL PROTEIN-LABELING MARKET, BY LABELING METHOD, THROUGH 2021 ($ MILLIONS)
    • TABLE 35: GLOBAL PROTEIN-LABELING MARKET FOR IN VITRO LABELING METHODS, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 36: GLOBAL PROTEIN-LABELING MARKET FOR IN VITRO LABELING METHODS BY TYPE, THROUGH 2021 ($ MILLIONS)
    • TABLE 37: GLOBAL PROTEIN-LABELING MARKET FOR NANOPARTICLE LABELING METHODS, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 38: GLOBAL PROTEIN-LABELING MARKET FOR SITE-SPECIFIC LABELING, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 39: SITE-SPECIFIC TAGS FOR PROTEIN-LABELING
    • TABLE 40: GLOBAL PROTEIN-LABELING MARKET FOR DYE-BASED LABELING, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 41: GLOBAL PROTEIN-LABELING MARKET FOR CO-TRANSLATIONAL LABELING, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 42: GLOBAL PROTEIN-LABELING MARKET FOR ENZYMATIC LABELING METHOD, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 43: GLOBAL PROTEIN-LABELING MARKET FOR IN VIVO LABELING, BY TYPE, THROUGH 2021 ($ MILLIONS)
    • TABLE 44: GLOBAL PROTEIN-LABELING MARKET FOR IN VIVO LABELING, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 45: GLOBAL PROTEIN-LABELING MARKET FOR RADIOACTIVE LABELING METHOD, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 46: RADIOACTIVE ELEMENTS
    • TABLE 47: GLOBAL PROTEIN-LABELING MARKET FOR PHOTOREACTIVE LABELING METHOD, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 48: GLOBAL PROTEIN-LABELING MARKET FOR BIORTHOGONAL LABELING METHOD, BY REGION, THROUGH 2021 ($ MILLIONS)
    • TABLE 49: KEY ACQUISTIONS, 2012-2016
    • TABLE 50: KEY PRODUCT LAUNCHES, 2014-2016
    • TABLE 51: KEY ANNOUNCED AGREEMENTS, 2014-2016
    • TABLE 52: PARTNERSHIP AND COLLABORATION STRATEGIES, BY COMPANY, 2014-2016 (%)
    • TABLE 53: NORTH AMERICAN PROTEIN-LABELING MARKET, BY PRODUCT TYPE, THROUGH 2021 ($ MILLIONS)
    • TABLE 54: EUROPEAN PROTEIN-LABELING MARKET, BY PRODUCT TYPE, THROUGH 2021 ($ MILLIONS)
    • TABLE 55: ASIA-PACIFIC PROTEIN-LABELING MARKET, BY PRODUCT TYPE, THROUGH 2021 ($ MILLIONS)
    • TABLE 56: REST OF THE WORLD PROTEIN-LABELING MARKET, BY PRODUCT TYPE, THROUGH 2021 ($ MILLIONS)
    • TABLE 57: ACTIVE MOTIF RECENT DEVELOPMENTS
    • TABLE 58: AGILENT TECHNOLOGIES RECENT DEVELOPMENTS
    • TABLE 59: AGILENT TECHNOLOGIES FINANCIALS, 2013-2015 ($ MILLIONS)
    • TABLE 60: BIO-RAD RECENT DEVELOPMENTS
    • TABLE 61: BIO-RAD FINANCIALS 2013-2015 ($ MILLIONS)
    • TABLE 62: CANDOR RECENT DEVELOPMENTS
    • TABLE 63: CAPRION RECENT DEVELOPMENTS
    • TABLE 64: F. HOFFMANN-LA ROCHE AG RECENT DEVELOPMENTS
    • TABLE 65: F. HOFFMANN-LA ROCHE AG FINANCIALS, 2013-2015 ($ MILLIONS)
    • TABLE 66: GENERAL ELECTRIC COMPANY RECENT DEVELOPMENTS
    • TABLE 67: GENERAL ELECTRIC COMPANY FINANCIALS, 2013-2015 ($ MILLIONS)
    • TABLE 68: INNOVA BIOSCIENCES RECENT DEVELOPMENTS
    • TABLE 69: KANEKA RECENT DEVELOPMENTS
    • TABLE 70: KANEKA FINANCIALS, 2013-2015 ($ MILLIONS)
    • TABLE 71: LI-COR RECENT DEVELOPMENTS
    • TABLE 72: LUMINEX, RECENT DEVELOPMENTS
    • TABLE 73: LUMINEX FINANCIALS 2013-2015 ($ MILLIONS)
    • TABLE 74: MERCK RECENT DEVELOPMENTS
    • TABLE 75: MERCK FINANCIALS, 2013-2015 ($ MILLIONS)
    • TABLE 76: NANOTEMPER RECENT DEVELOPMENTS
    • TABLE 77: NEW ENGLAND BIOLABS INC. RECENT DEVELOPMENTS
    • TABLE 78: PERKINELMER RECENT DEVELOPMENTS
    • TABLE 79: PERKINELMER FINANCIALS, 2013-2015 ($ MILLIONS)
    • TABLE 80: PROMEGA RECENT DEVELOPMENTS
    • TABLE 81: PROMEGA FINANCIALS, 2013-2015 ($ MILLIONS)
    • TABLE 82: SERACARE LIFE SCIENCES RECENT DEVELOPMENTS
    • TABLE 83: TAKARA BIO RECENT DEVELOPMENTS
    • TABLE 84: TAKARA BIO FINANCIALS, 2013-2015 ($ MILLIONS)
    • TABLE 85: THERMO FISHER RECENT DEVELOPMENTS
    • TABLE 86: THERMO FISHER FINANCIALS, 2013-2015 ($ MILLIONS)
    • TABLE 87: QIAGEN RECENT DEVELOPMENTS
    • TABLE 88: QIAGEN FINANCIALS, 2013-2015 ($ MILLIONS)
    • TABLE 89: NORTH AMERICAN PATENTS
    • TABLE 90: EUROPEAN PATENTS
    • TABLE 91: ASIA-PACIFIC REGION PATENTS
    • TABLE 92: REST OF THE WORLD PATENTS

LIST OF FIGURES

  • SUMMARY FIGURE: GLOBAL PROTEIN-LABELING MARKET, BY REGION, 2015-2021 ($ MILLIONS)
    • FIGURE 1: KEY PROTEIN LABELS USED FOR PROTEIN LABELING
    • FIGURE 2: COMPONENTS INVOLVED IN AN EFFECTIVE GOOD LABORATORY PRACTICE INVESTIGATION
    • FIGURE 3: KEY GOOD LABORATORY PRACTICE ELEMENTS
    • FIGURE 4: CELL-BASED ASSAY TYPES
    • FIGURE 5: FLUORESCENCE MICROSCOPY PROTOCOL
    • FIGURE 6: PROTEOMICS STUDY APPROACHES
    • FIGURE 7: ELISA TYPES
    • FIGURE 8: DIRECT ELISA PROTOCOL
    • FIGURE 9: INDIRECT ELISA PROTOCOL
    • FIGURE 10: COMPETITIVE ELISA PROTOCOL
    • FIGURE 11: SANDWICH ELISA PROTOCOL
    • FIGURE 12: METHODS FOR PROTEIN ARRAY DETECTION
    • FIGURE 13: PROTEIN-LABELING PRODUCTS
    • FIGURE 14: PROTEIN-LABELING METHODS
    • FIGURE 15: KEY NANOPARTICLE FORMS USED IN BIOCONJUGATION
    • FIGURE 16: REACTIVE FLUORESCENT AGENTS
    • FIGURE 17: ENZYMES USED FOR PROTEIN LABELING
    • FIGURE 18: STEPS INVOLVED IN VIVO PROTEIN-LABELING
    • FIGURE 19: RADIOACTIVE LABELING OF PROTEINS
    • FIGURE 20: GENERAL PROTOCOL FOR PHOTOLABELING OF PROTEINS
    • FIGURE 21: KEY COMPETITIVE STRATEGIES, 2014-2016 (%)
    • FIGURE 22: MERGER AND ACQUISTION STRATEGIES BY COMPANY, 2014-2016
    • FIGURE 23: PRODUCT LAUNCH STRATEGIES, BY COMPANY, 2014-2016
    • FIGURE 24: PARTNERSHIP AND COLLABORATION STRATEGIES, BY COMPANY, 2014-2016 (%)
    • FIGURE 25: PARTNERSHIP AND COLLABORATION STRATEGIES, BY COMPANY, 2014-2016 (%)
    • FIGURE 26: GLOBAL MARKET FOR PROTEIN-LABELING, BY REGION, 2015 (%)
    • FIGURE 27: PATENTS GRANTED FOR PROTEIN-LABELING RESEARCH, BY REGION, 2015 (%)
    • FIGURE 28: TOP 2,500 COMPANIES RESEARCH AND DEVELOPMENT INVESTMENT, BY REGION, 2014 (%)
    • FIGURE 29: TOP 2,500 EUROPEAN COMPANIES RESEARCH AND DEVELOPMENT INVESTMENT, BY COUNTRY, 2014 (%)
    • FIGURE 30: PATENTS REGISTERED AND APPROVED IN NORTH AMERICA, EUROPE, ASIA-PACIFIC AND THE REST OF THE WORLD, 2013-2016 (%)
    • FIGURE 31: PATENT ANALYSIS, BY MARKET APPLICANT, 2013-2016 (%)
    • FIGURE 32: PATENT ANALYSIS, BY YEAR, 2013-2016 (%)
Back to Top